China Companion Diagnostics Oncology Market: Regulatory Framework and Central Role in Targeted Cancer Therapies
The China Companion Diagnostics (CDx) Oncology Market is a critical and high-growth sector, fundamentally essential to the implementation of targeted cancer therapies and the realization of personalized medicine in China. CDx tests are in vitro diagnostic devices that provide information essential for the safe and effective use of a corresponding therapeutic product (drug). In oncology, CDx is crucial for identifying patients who are most likely to benefit from specific, high-cost targeted drugs, making the diagnostic test a gatekeeper for therapy.
29 Views